Boosting Medical Manufacturing in Distressed Areas and Strengthening Supply Chains.
This act aims to support the production of medicines and medical equipment in the United States, especially in economically struggling areas. Companies that relocate production from abroad or produce critical public health products may receive greater tax benefits. This is intended to ensure better access to medicines and strengthen the nation's health security.
Key points
Companies manufacturing medical products in designated economically distressed zones can receive tax credits, potentially leading to new job creation.
Increased incentives for companies that bring medical production back to the U.S., especially from countries posing supply chain risks.
Support for the production of medicines and medical products crucial for public health, particularly for vulnerable groups like children, pregnant women, and older adults.
Introduced
Citizen Poll